Kardigan, Inc. (KARD) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 1.33B USD. 52-week range 12.23 to 27.00 USD. Data as of 2026-10-09.
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study ...